BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bahbahani H, AlTurki A, Dawas A, Lipman ML. Warfarin anticoagulation in hemodialysis patients with atrial fibrillation: comparison of nephrologist-led and anticoagulation clinic-led management.BMC Nephrol. 2018;19:4. [PMID: 29310600 DOI: 10.1186/s12882-017-0809-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Lee SL, Ong TJ, Mazlan-Kepli W, Mageswaran A, Tan KH, Abd-Malek AM, Cronshaw R. Patients’ time in therapeutic range on warfarin among atrial fibrillation patients in Warfarin Medication Therapy Adherence Clinic. World J Cardiol 2021; 13(9): 483-492 [PMID: 34621493 DOI: 10.4330/wjc.v13.i9.483] [Reference Citation Analysis]
2 Blum D, Beaubien-Souligny W, Battistella M, Tseng E, Harel Z, Nijjar J, Nazvitch E, Silver SA, Wald R. Quality Improvement Program Improves Time in Therapeutic Range for Hemodialysis Recipients Taking Warfarin. Kidney Int Rep 2020;5:159-64. [PMID: 32043029 DOI: 10.1016/j.ekir.2019.10.011] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Reilly RF, Jain N. Warfarin in nonvalvular atrial fibrillation-Time for a change? Semin Dial 2019;32:520-6. [PMID: 31209952 DOI: 10.1111/sdi.12829] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]